DSBio Consulting LLC
Consulting firm providing advisory and management services for biomedical technology development with a focus on health security and public‑health diagnostics. Services include technology readiness assessment, funding and solicitation navigation, proposal development, regulatory strategy for FDA authorization/approval, and program/project management. The founder has prior leadership roles in U.S. government health security programs and involvement in BARDA and COVID‑19 diagnostic acceleration efforts.
Industries
N/A
Services
Technology assessment and TRL evaluation
Consultation to assess technology maturity and alignment with funder and partner requirements; includes a project plan with timelines and milestones.
Funding strategy and proposal development
Identify funding opportunities, interpret solicitations, and support proposal preparation for mechanisms such as RFPs, BAAs, SBIR and STTR.
Regulatory and commercialization strategy
Advise on regulatory pathways toward FDA authorization/approval and on commercialization, procurement, and distribution considerations.
Program and project management for public‑health programs
Management support for government‑funded programs and rapid response efforts, including schedule, milestones, and contractor coordination.
Technology assessment and TRL evaluation
Consultation to assess technology maturity and alignment with funder and partner requirements; includes a project plan with timelines and milestones.
Funding strategy and proposal development
Identify funding opportunities, interpret solicitations, and support proposal preparation for mechanisms such as RFPs, BAAs, SBIR and STTR.
Regulatory and commercialization strategy
Advise on regulatory pathways toward FDA authorization/approval and on commercialization, procurement, and distribution considerations.
Program and project management for public‑health programs
Management support for government‑funded programs and rapid response efforts, including schedule, milestones, and contractor coordination.
Expertise Areas
- Health security and biodefense program management
- Diagnostic assay validation and deployment
- Technology readiness assessment and evaluation
- Funding and solicitation strategy (RFP/BAA, SBIR/STTR)
Key Technologies
- Diagnostic assay validation
- Technology readiness level (TRL) assessment
- Regulatory submission strategy (FDA authorization/approval)
- Grant and solicitation strategy (RFP/BAA, SBIR/STTR)